Results
1
1 companies
Biodyne
Market Cap: ₩241.4b
Engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea.
A314930
₩8,000.00
7D
-13.0%
1Y
-44.8%
